AdvisorNet Financial Inc lessened its position in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 51.1% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 347 shares of the financial services provider’s stock after selling 362 shares during the period. AdvisorNet Financial Inc’s holdings in Aflac were worth $37,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in the company. AG2R LA Mondiale Gestion D Actifs bought a new stake in Aflac in the 1st quarter valued at $2,070,000. Belpointe Asset Management LLC bought a new stake in shares of Aflac in the first quarter valued at about $551,000. Golden State Wealth Management LLC grew its stake in shares of Aflac by 121.9% in the first quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 167 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. grew its stake in shares of Aflac by 11.8% in the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 32,982 shares of the financial services provider’s stock valued at $3,478,000 after acquiring an additional 3,484 shares in the last quarter. Finally, Strs Ohio acquired a new stake in Aflac in the 1st quarter worth about $2,626,000. Institutional investors own 67.44% of the company’s stock.
Aflac Trading Up 1.7%
Shares of AFL stock opened at $111.36 on Friday. Aflac Incorporated has a fifty-two week low of $96.95 and a fifty-two week high of $115.50. The stock’s fifty day moving average price is $105.44 and its two-hundred day moving average price is $105.25. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.11 and a current ratio of 0.11. The company has a market cap of $59.56 billion, a PE ratio of 25.25, a P/E/G ratio of 3.11 and a beta of 0.85.
Aflac declared that its Board of Directors has approved a share buyback plan on Tuesday, August 12th that permits the company to repurchase 100,000,000 shares. This repurchase authorization permits the financial services provider to purchase shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its shares are undervalued.
Aflac Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 2nd. Investors of record on Wednesday, August 20th were issued a dividend of $0.58 per share. The ex-dividend date of this dividend was Wednesday, August 20th. This represents a $2.32 annualized dividend and a dividend yield of 2.1%. Aflac’s payout ratio is 52.61%.
Insider Transactions at Aflac
In related news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $102.57, for a total value of $102,570.00. Following the completion of the transaction, the director owned 25,105 shares of the company’s stock, valued at $2,575,019.85. This represents a 3.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.90% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
Several brokerages have recently commented on AFL. Keefe, Bruyette & Woods raised their target price on shares of Aflac from $106.00 to $108.00 and gave the stock a “market perform” rating in a report on Monday, August 11th. Wall Street Zen upgraded Aflac from a “sell” rating to a “hold” rating in a research note on Saturday, August 9th. Barclays set a $98.00 price objective on Aflac and gave the company an “underweight” rating in a report on Monday, July 7th. Morgan Stanley increased their target price on Aflac from $108.00 to $113.00 and gave the stock an “equal weight” rating in a report on Monday, August 18th. Finally, Evercore ISI restated an “underperform” rating and issued a $106.00 price target (up previously from $105.00) on shares of Aflac in a research report on Thursday, August 14th. Three equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $109.15.
View Our Latest Analysis on AFL
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
- Five stocks we like better than Aflac
- Do ETFs Pay Dividends? What You Need to Know
- 3 Healthcare Stocks Using AI to Drive Growth
- Industrial Products Stocks Investing
- Get Exposure to Millennials’ Purchasing Power With This ETF
- What is the MACD Indicator and How to Use it in Your Trading
- Why a $4.5 Billion Smart Debt Move Is Fueling Dell’s AI Ambitions
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.